
Gifting Made Simple
Give the Gift of ChoiceClick below to purchase a Bramalea City Centre eGift Card that can be used at participating retailers at Bramalea City Centre.Purchase HereHome
Antimicrobial Stewardship: Where We've Come and Where We're Going, An Issue of Infectious Disease Clinics of North America, 1e
Coles
Loading Inventory...
Antimicrobial Stewardship: Where We've Come and Where We're Going, An Issue of Infectious Disease Clinics of North America, 1e in Brampton, ON
Current price: $146.99

Coles
Antimicrobial Stewardship: Where We've Come and Where We're Going, An Issue of Infectious Disease Clinics of North America, 1e in Brampton, ON
Current price: $146.99
Loading Inventory...
Size: Hardcover
*Product information and pricing may vary - to confirm current pricing, availability, shipping, and return information please contact Coles. In the event of a pricing discrepancy, the retailer's price will apply.
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field.
In this issue of Infectious Disease Clinics of North America, guest editors Drs. Emily Sydnor Spivak and Sage Greenlee bring their considerable expertise to the topic of Antimicrobial Stewardship: Where We Have Come and Where We Are Going. Throughout the last decade, the field of antimicrobial stewardship has undergone exponential growth due to heightened awareness of antimicrobial use and emerging multidrug-resistant organisms. Additionally, the COVID-19 pandemic highlighted systemic and persistent health disparities in the United States. In this issue, top experts provide a recap of the progress made over the last decade in antimicrobial stewardship and provide direction for next steps in this ever-growing field.





















